select trial semaglutide cardiovascular outcomes without diabetes 2023 From drugs... to weight loss drugs... to cardiometabolic drugs? The may mark the beginning of that transition. Where do you think GLP-1 receptor agonists will stand 10 years from Designing Next-Generation Cardiometabolic Outcome Trials

Compounded semaglutide is made by specialty pharmacies and isnt FDA-approved, but it may be available when the branded version is in short supply

CagriSema uses semaglutide, a pure GLP-1 agonist, not tirzepatide's dual GIP/GLP-1 mechanism

LOSS OF BONE DENSITY AND MUSCLE STRENGTH Muscle and bone aging contribute significantly to morbidity and mortality in older populations, affecting the overall quality of life

I am an injection instructor for Allergan, and I think the addition of Kybella to their portfolio of injectables is going to be a home run

GHK-Cu is a tripeptide bound to a copper ion, composed of three amino acids: Glycine Histidine Lysine When combined